Intermittent fasting reimagined with formoline Intervall 5:2

Certmedica launches user-oriented treatment unit for enhanced intermittent fasting

With formoline Intervall 5:2, Certmedica is introducing a user-centered treatment unit for weight management. The combination pack of the medical devices formoline L112 and formoline mannan specifically supports the implementation of 5:2 intermittent fasting, improves everyday usability, and promotes adherence and long-term compliance through a clear structure and evidence-based principles of action.

More suitability for everyday use for users

In recent years, intermittent fasting has become one of the most discussed nutritional approaches in medicine, nutritional science, and preventive research. Intermittent fasting is based on a structured alternation between phases of normal food intake and phases of reduced energy intake or fasting. This approach increasingly reflects the understanding that not only the amount of calories, but also eating rhythms and metabolic breaks play a central role in metabolic processes.

In practice, however, intermittent fasting often fails due to a lack of feasibility and declining compliance. formoline Intervall 5:2 addresses this challenge in a targeted manner: The clearly structured application concept reduces the cognitive and practical complexity of the fasting concept by providing specific, day-dependent instructions and guiding the user through a clearly structured weekly logic, as it does not require the same behavior on all days, but specifically distinguishes between five eating days and two fasting days. This allows the calorie deficit to be achieved in a planned manner – without daily deprivation.

Targeted support on meal days

On the five meal days per week, formoline L112 gives users more flexibility in their diet. The physically active fiber polyglucosamine with the specification L112 binds some of the dietary fats in the digestive tract, thereby reducing the calorie intake from high-fat meals.

Users benefit from:

• Fewer calories despite normal, balanced meals
• An effect only in the digestive tract, without systemic stress
• Medically tested, long-term support

The ability to eat normally and balanced on meal days is considered a key driver for long-term compliance in the 5:2 concept

Easier fasting days thanks to satiety

For many users, the biggest hurdle to intermittent fasting is the fasting days. formoline mannan targets this issue: the natural fiber konjac mannan swells in the stomach and provides a pleasant feeling of satiety, making it easier to stick to the reduced calorie intake of approx. 500–600 kcal per day.

Advantages:

• Less hunger and cravings on fasting days
• Better adherence to the fasting plan
• Supported weight loss as part of a low-calorie diet

This reduces dependence on pure self-discipline—a key factor for sustainable adherence.

Treatment unit: Guidance and adherence to therapy

formoline Interval 5:2 is designed as a 4-week treatment unit. The combination pack guides you step by step through intermittent fasting and offers:

• A clear structure instead of complex diet rules
• Better guidance on the weekly rhythm
• A defined start and evaluation period

Scientifically based – practically implemented

The effectiveness of the individual components of the treatment unit has been scientifically proven:

• Clinical study data on weight loss is available for polyglucosamine L112, and it is CE-certified as a medical device.
• Konjac mannan has the approved health claim “Glucomannan contributes to weight loss in the context of a low-calorie diet” in accordance with Regulation (EC) No. 432/2012.

For users, this means medically and regulatorily proven support combined with high suitability for everyday use.

Relevance for professionals

For pharmacists, doctors, and nutrition therapists, formoline® Intervall 5:2 offers a clearly structured, easily explainable concept that combines medical and nutritional approaches, specifically addresses the most common causes of poor compliance, and facilitates practical advice—with clearly communicable added value for the user.

The linked additional information is available in German only.